Acer Therapeutics Derivative Settlement Gets Initial Nod
A federal judge in Massachusetts gave an initial nod to the proposed settlement of a trio of shareholder derivative suits against Acer Therapeutics Inc. that would see the company making a...To view the full article, register now.
Already a subscriber? Click here to view full article